Clinical Investigation on the Effects of a Vegetable Juice Treatment

\*\*\*Inclusion Criteria\*\*\* * Age 40 to 65 yrs * Subject's body mass index is between 18.5 - 34.9 kg/m2 * Subject is willing and able to comply with the study protocols * Subject is willing to consume a vegetable-based beverage daily for three months \*\*\*Exclusion Criteria\*\*\* * Physical signs of health impairment * Uncontrolled diabetes or hypertension * Pregnant or lactating * Active tuberculosis or lung disease (i.e. COPD) * Renal or Liver disease * Heart Disease, which includes Cardiovascular events and Stroke * Cushing's syndrome * Exercise trained individuals * History of psychiatric disorders i.e. schizophrenia or bi-polar or depression treated with antidepressants within the last 1 year * Anxiety medications * Use of MAOI inhibitors within the last 1 year (e.g., phenelzine (Nardil), tranylcypromine (Parnate), etc.) * Quality of life score of 21 or above * Routine use of prescription drugs or over-the counter medications, which may potentially modulate the outcome of this study; including antibiotics, aspirin and aspirin-containing formulations, COX-2 inhibitors, antihistamines, corticosteroids, erectile dysfunction drugs * Asthma (can be worsened by mild to moderate food allergies) * Indications of substance or alcohol abuse within the last 3 years * The volunteer is undergoing nicotine cessation therapy * Laboratory values outside the reference range if determined to be clinically significant by Dr. M. Eric Gershwin * Individuals with known salt-sensitive hypertension * History of stage 1 high blood pressure defined as systolic \> 140 and diastolic \> 90, with or without use of HTN medications * Multi-Vitamin use other than a One-A-Day essential * Use of herbal or plant-based supplements; omega-3 fatty acids, and fish oils and unwilling to discontinue use while participating in the study * Allergies to vegetables